Improving outcomes of severe infections by multidrug-resistant pathogens with polyclonal IgM-enriched immunoglobulins

This publication has 17 references indexed in Scilit:

• In vitro and in vivo activity of hyperimmune globulin preparations against multiresistant nosocomial pathogens
  Infection, 2014
• Bloodstream infections and sepsis in Greece: over-time change of epidemiology and impact of de-escalation on final outcome
  BMC Infectious Diseases, 2014
• Kinetics of circulating immunoglobulin M in sepsis: relationship with final outcome
  Critical Care, 2013
• Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach
  The Lancet Infectious Diseases, 2013
• High rate of colistin resistance among patients with carbapenem-resistant Klebsiella pneumoniae infection accounts for an excess of mortality
  Clinical Microbiology and Infection, 2013
• Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
  Clinical Microbiology and Infection, 2012
• Pharmacokinetics and safety of panobacumab: specific adjunctive immunotherapy in critical patients with nosocomial Pseudomonas aeruginosa O11 pneumonia
  Journal of Antimicrobial Chemotherapy, 2011
• Bacteraemia due to multidrug-resistant Gram-negative bacilli in cancer patients: risk factors, antibiotic therapy and outcomes
  Journal of Antimicrobial Chemotherapy, 2010
• The International Sepsis Forum Consensus Conference on Definitions of Infection in the Intensive Care Unit
  Critical Care Medicine, 2005
• A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation
  Journal of Chronic Diseases, 1987